Literature DB >> 25568985

Enrichment and enumeration of circulating tumor cells by efficient depletion of leukocyte fractions.

Shiyang Wu, Zhiming Liu, Suyan Liu, Li Lin, Weiwei Yang, Jiasen Xu.   

Abstract

Entities:  

Year:  2015        PMID： 25568985     DOI： 10.1515/cclm-2015-5000

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  10 in total

Review 1.  Fusion gene and splice variant analyses in liquid biopsies of lung cancer patients.

Authors:  Cristina Aguado; Ana Giménez-Capitán; Niki Karachaliou; Ana Pérez-Rosado; Santiago Viteri; Daniela Morales-Espinosa; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-10

2.  PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice.

Authors:  Xiao-Cui Hong; Qi-Lian Liang; Man Chen; Hai-Xia Yang; Jie Huang; Si-Lin Yi; Zhen-Wei Wang; Hai-Yan Liang; Ding-Yue Zhang; Zeng-Yi Huang
Journal:  Front Oncol       Date:  2022-04-29       Impact factor: 5.738

3.  Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis.

Authors:  Long Cui; Joseph Kwong; Chi Chiu Wang
Journal:  J Ovarian Res       Date:  2015-06-16       Impact factor: 4.234

4.  Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer.

Authors:  Fengjie Wu; Jun Zhu; Yongjiang Mao; Xiaomei Li; Baoguang Hu; Dianliang Zhang
Journal:  Dis Markers       Date:  2017-12-21       Impact factor: 3.434

Review 5.  Circulating tumor cells in early stage lung adenocarcinoma: a case series report and literature review.

Authors:  Xu-Rui Jin; Lu-Yao Zhu; Kai Qian; Yong-Geng Feng; Jing-Hai Zhou; Ru-Wen Wang; Li Bai; Bo Deng; Naixin Liang; Qun-You Tan
Journal:  Oncotarget       Date:  2017-04-04

6.  Significance of circulating tumor cells in osteosarcoma patients treated by neoadjuvant chemotherapy and surgery.

Authors:  Zhen-Jie Wu; Jia-Chang Tan; Xiong Qin; Bin Liu; Zhen-Chao Yuan
Journal:  Cancer Manag Res       Date:  2018-09-10       Impact factor: 3.989

7.  Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer.

Authors:  Sha-Sha Jiang; Chun-Guo Mao; Yong-Geng Feng; Bin Jiang; Shao-Lin Tao; Qun-You Tan; Bo Deng
Journal:  World J Clin Cases       Date:  2021-04-26       Impact factor: 1.337

Review 8.  Circulating tumor cells: biology and clinical significance.

Authors:  Danfeng Lin; Lesang Shen; Meng Luo; Kun Zhang; Jinfan Li; Qi Yang; Fangfang Zhu; Dan Zhou; Shu Zheng; Yiding Chen; Jiaojiao Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-11-22

9.  Combination of Preoperative Circulating Tumor Cell Count and Neutrophil-Lymphocyte Ratio for Prognostic Prediction in Hepatocellular Carcinoma Patients after Curative Hepatectomy.

Authors:  Hang-Hang Ni; Xi-Hua Yang; Cheng-Lei Yang; Qian Zhang; Jing-Xuan Xu; Lu-Nan Qi; Bang-De Xiang
Journal:  Biomed Res Int       Date:  2022-07-16       Impact factor: 3.246

Review 10.  Breast cancer circulating tumor cells with mesenchymal features-an unreachable target?

Authors:  Justyna Topa; Peter Grešner; Anna J Żaczek; Aleksandra Markiewicz
Journal:  Cell Mol Life Sci       Date:  2022-01-20       Impact factor: 9.261
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.